Back to Companies
Barinthus Biotherapeutics plc.
BRNSNasdaqCIK: 0001828185
Recent Form 4 activity at Barinthus Biotherapeutics plc. (BRNS) spans 9 filings across 9 insiders (no open-market buying or selling). Enright William (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $10.3M by Enright William. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$16.4M
Purchases
$0
Sales
$0
Unique Insiders
9
Recent Insider Trades
9 loaded
| Sep 9 | BRNS Barinthus Biotherapeutics plc. | Phillips Anne M. | Director | Disposed | $772.4K |
| Sep 11 | BRNS Barinthus Biotherapeutics plc. | Oxford Science Enterprises plc | Insider | Other | $976.6K |
| Sep 9 | BRNS Barinthus Biotherapeutics plc. | Enright William | Chief Executive Officer, Director | Disposed | $10.3M |
| Sep 9 | BRNS Barinthus Biotherapeutics plc. | Morgon Pierre A. | Director | Disposed | $772.4K |
| Sep 9 | BRNS Barinthus Biotherapeutics plc. | DAWES KAREN A | Director | Disposed | $772.4K |
| Sep 9 | BRNS Barinthus Biotherapeutics plc. | Wright Robin | Director | Disposed | $772.4K |
| Sep 9 | BRNS Barinthus Biotherapeutics plc. | Hooftman Leon | Chief Medical Officer | Grant | $530.3K |
| Sep 9 | BRNS Barinthus Biotherapeutics plc. | Scheeren Joseph | Director | Disposed | $772.4K |
| Sep 9 | BRNS Barinthus Biotherapeutics plc. | Hammacher Alex | Director | Disposed | $772.4K |
9 filings